Literature DB >> 18669928

Fine-tuning the angiogenic response to vascular endothelial growth factor.

James K Liao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18669928      PMCID： PMC2662039          DOI： 10.1161/CIRCRESAHA.108.181628

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  23 in total

1.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.

Authors:  B Bussolati; C Dunk; M Grohman; C D Kontos; J Mason; A Ahmed
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

3.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

4.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

Authors:  K J Kim; B Li; J Winer; M Armanini; N Gillett; H S Phillips; N Ferrara
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

5.  Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.

Authors:  Jun-ichiro Nishi; Tohru Minamino; Hideyuki Miyauchi; Aika Nojima; Kaoru Tateno; Sho Okada; Masayuki Orimo; Junji Moriya; Guo-Hua Fong; Kenji Sunagawa; Masabumi Shibuya; Issei Komuro
Journal:  Circ Res       Date:  2008-06-26       Impact factor: 17.367

Review 6.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

7.  Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.

Authors:  Shakil Ahmad; Asif Ahmed
Journal:  Circ Res       Date:  2004-10-07       Impact factor: 17.367

8.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors:  Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

9.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

10.  Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway.

Authors:  Hideyuki Miyauchi; Tohru Minamino; Kaoru Tateno; Takeshige Kunieda; Haruhiro Toko; Issei Komuro
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598
View more
  4 in total

1.  Urgent call for reconsideration of chronic kidney disease.

Authors:  Narisa Futrakul; Prasit Futrakul
Journal:  World J Nephrol       Date:  2012-12-06

Review 2.  VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications.

Authors:  Jincai Luo; Yan Xiong; Xiaofan Han; Yao Lu
Journal:  J Mol Med (Berl)       Date:  2011-03-02       Impact factor: 4.599

3.  Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndrome.

Authors:  Rashmi Jadhav; Tracy Dodd; Erika Smith; Erin Bailey; Angelo L Delucia; James C Russell; Rowan Madison; Barry Potter; Kenneth Walsh; Hanjoong Jo; Petra Rocic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

4.  Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes.

Authors:  Narisa Futrakul; Prasit Futrakul
Journal:  Int J Vasc Med       Date:  2011-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.